Literature DB >> 9481526

A diet rich in walnuts favourably influences plasma fatty acid profile in moderately hyperlipidaemic subjects.

A Chisholm1, J Mann, M Skeaff, C Frampton, W Sutherland, A Duncan, S Tiszavari.   

Abstract

OBJECTIVE: To compare two low fat diets one rich in walnuts on parameters of lipid metabolism in a group of hyperlipidaemic subjects.
DESIGN: A randomised cross over study.
SETTING: Department of Human Nutrition, University of Otago, Dunedin, New Zealand
SUBJECTS: Twenty one men with mean (s.d.) levels of total and LDL cholesterol of 6.58 (0.60) and 4.63 (0.58) respectively.
INTERVENTIONS: For two periods of four weeks subjects were asked to consume two low fat diets (fat 30% total energy), one containing, on average, 78 g/d walnuts. Walnuts obtained through Lincoln University and the Walnut Growers Group (South Canterbury).
RESULTS: Participants reported a higher total fat intake on the walnut diet (38% compared with 30% on the low fat diet P < 0.01) The most consistent change in fatty acid profile of triacylglycerol, phospholipid and cholesterol ester on the walnut diet was a significant (P < 0.01) increase in linoleic acid. Triacylglycerol linolenate also increased significantly (P < 0.01). Total and LDL cholesterol were lower on both experimental diets than at baseline, 0.25 mmol/l and 0.36 mmol/l respectively on the walnut diet and 0.13 mmol/l and 0.20 mmol/l respectively on the low fat diet. High density lipoprotein cholesterol was higher on both the walnut and low fat diets when compared to baseline (0.15 mmol/l and 0.12 mmol/l, respectively). When comparing the walnut and low fat diets only apo B was significantly lower (P < 0.05) on the walnut diet.
CONCLUSIONS: Despite an unintended increase in the total fat intake on the walnut diet, fatty acid profile of the major lipid fractions showed changes which might be expected to reduce risk of cardiovascular disease. The reduction of apolipoprotein B suggests a reduction in lipoprotein mediated risk, the relatively low myristic acid content of both diets perhaps explaining the absence of more extensive differences in lipoprotein levels on the two diets.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9481526     DOI: 10.1038/sj.ejcn.1600507

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  18 in total

Review 1.  Effects of tree nuts on blood lipids, apolipoproteins, and blood pressure: systematic review, meta-analysis, and dose-response of 61 controlled intervention trials.

Authors:  Liana C Del Gobbo; Michael C Falk; Robin Feldman; Kara Lewis; Dariush Mozaffarian
Journal:  Am J Clin Nutr       Date:  2015-11-11       Impact factor: 7.045

Review 2.  The impact of nuts on diabetes and diabetes risk.

Authors:  Jennifer C Lovejoy
Journal:  Curr Diab Rep       Date:  2005-10       Impact factor: 4.810

3.  Association of nut consumption with CVD risk factors in young to middle-aged adults: The Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  So-Yun Yi; Lyn M Steffen; Xia Zhou; James M Shikany; David R Jacobs
Journal:  Nutr Metab Cardiovasc Dis       Date:  2022-07-31       Impact factor: 4.666

4.  Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review.

Authors:  Deirdre K Banel; Frank B Hu
Journal:  Am J Clin Nutr       Date:  2009-05-20       Impact factor: 7.045

5.  Effects of walnut consumption on blood lipids and other cardiovascular risk factors: an updated meta-analysis and systematic review of controlled trials.

Authors:  Marta Guasch-Ferré; Jun Li; Frank B Hu; Jordi Salas-Salvadó; Deirdre K Tobias
Journal:  Am J Clin Nutr       Date:  2018-07-01       Impact factor: 7.045

6.  Effect of moderate walnut consumption on lipid profile, arterial stiffness and platelet activation in humans.

Authors:  J N Din; S M Aftab; A W Jubb; F H Carnegy; K Lyall; J Sarma; D E Newby; A D Flapan
Journal:  Eur J Clin Nutr       Date:  2010-11-03       Impact factor: 4.016

7.  Protective effects of walnut extract against amyloid beta peptide-induced cell death and oxidative stress in PC12 cells.

Authors:  Balu Muthaiyah; Musthafa M Essa; Ved Chauhan; Abha Chauhan
Journal:  Neurochem Res       Date:  2011-06-25       Impact factor: 3.996

8.  Validation of the Antiproliferative Effects of Organic Extracts from the Green Husk of Juglans regia L. on PC-3 Human Prostate Cancer Cells by Assessment of Apoptosis-Related Genes.

Authors:  Ali A Alshatwi; Tarique N Hasan; Gowhar Shafi; Naveed Ahmed Syed; Abdullah H Al-Assaf; Mohammed S Alamri; Abdrohman S Al-Khalifa
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-06       Impact factor: 2.629

9.  Effects of walnut consumption on endothelial function in type 2 diabetic subjects: a randomized controlled crossover trial.

Authors:  Yingying Ma; Valentine Yanchou Njike; John Millet; Suparna Dutta; Kim Doughty; Judith A Treu; David L Katz
Journal:  Diabetes Care       Date:  2009-10-30       Impact factor: 19.112

10.  The effect of walnut intake on factors related to prostate and vascular health in older men.

Authors:  Kim J Spaccarotella; Penny M Kris-Etherton; William L Stone; Deborah M Bagshaw; Valerie K Fishell; Sheila G West; Frank R Lawrence; Terryl J Hartman
Journal:  Nutr J       Date:  2008-05-02       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.